Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Amylin Pharmaceuticals Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-7 of 7
» View latimes.com items only
    Jul 16, 2012 |Story| Baltimore Sun
  1. GlaxoSmithKline to acquire Human Genome Sciences

    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion. GlaxoSmithKline boosted its offer for...

    Tags: Biotechnology, Lupus, Drugs and Medicines, Patents, Copyrights and Trademarks, Diabetes

  2. Oct 18, 2010 |Story| Chicago Tribune
  3. Some drugs raising red flags

    At drug company-sponsored seminars, Illinois doctors are speaking about dozens of commonly prescribed medications that help millions of patients. But questions have been raised about some of the drugs: •Atypical antipsychotics such as Zyprexa (...

    Tags: Health, Drugs and Medicines, Merck & Company Incorporated, Diseases and Illnesses, Menopause

  4. Aug 17, 2010 |Story| Associated Press
  5. Eli Lilly halts development of potential Alzheimer's drug

    Eli Lilly and Co. has stopped developing a potential Alzheimer's disease treatment at a time when the drugmaker is searching wide and far for new drugs to fill a large revenue hole that will form starting next year.
    The Associated Press
    Eli Lilly and Co. has stopped developing a potential Alzheimer's disease treatment at a time when the drugmaker is searching wide and far for new drugs to fill a large revenue hole that will form starting next year. The Indianapolis company said...

    Tags: Cancer, Companies and Corporations, Johnson & Johnson Inc., Health, Patents, Copyrights and Trademarks

  6. Jul 23, 2006 |Story| Chicago Tribune
  7. The week ahead

    Chicago Tribune
    Monday: -- Earnings: Altera Corp.; American Express Co.; Amylin Pharmaceuticals Inc.; Avaya Inc.; BellSouth Corp.; Centex Corp.; Kraft Foods Inc.; Pactiv Corp.; Quest Diagnostics Inc.; SanDisk Corp.; Texas Instruments Inc. Tuesday: -- July consumer...

    Tags: Dover Corporation, Aetna Inc., General Motors Corp., Rohm & Haas Company, FPL Group

  8. Jun 21, 2007 |Story| Chicago Tribune
  9. Diabetes pill's sales health in question

    Heading into this weekend's American Diabetes Association meeting in Chicago, industry analysts are predicting a continued decline of the diabetes pill Avandia. Avandia, sold by British drug giant GlaxoSmithKline PLC, has been losing market share in...

    Tags: Health, Finance, Obesity, Japan, Drugs and Medicines

  10. Jun 17, 2007 |Story| Tribune Media Services
  11. Prudential financial remains rock solid as its stock surges

    Tribune Media Services columnist
    Q: Can I count on my shares of Prudential Financial Inc. to continue going up in price? --C.M., via the Internet A: The second-largest U.S. life insurer, behind only MetLife, has a strong brand identity. Backing that up is $2 trillion worth of policies...

    Tags: Saudi Arabia, Health, Hospitals and Clinics, Morningstar Incorporated, H&R Block Inc.

  12. Aug 26, 2008 |Story| WXIN-LTV
  13. Companies report 4 new deaths with diabetes drug

    Eli Lilly and Amylin Pharmaceuticals report four new deaths in patients taking the diabetes medication Byetta. An executive from Indianapolis-based Eli Lilly says the FDA is aware of the additional deaths but did not announce them because they involved...

    Tags: Diabetes, Pharmaceuticals, Lilly Eli & Co, Health, Drugs and Medicines

Advertisement
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Amylin Pharmaceuticals Incorporated Photos
Yasuchika Hasegawa heads Japanese drug maker Takeda Pha...
(December 4, 2009)
Yasuchika Hasegawa